CARDLYTICS INC's ticker is and the CUSIP is 14161WAB1. A total of 12 filers reported holding CARDLYTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 16,025,000 | $9,775,250 | 0.76% |
| LINDEN ADVISORS LP | 58,112,000 | $36,491,140 | 0.37% |
| WOLVERINE ASSET MANAGEMENT LLC | 33,928,000 | $21,104,688 | 0.24% |
| DeepCurrents Investment Group LLC | 5,663,000 | $3,433,442 | 0.15% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 20,160,000 | $12,511,296 | 0.06% |
| GABELLI FUNDS LLC | 4,560,000 | $2,834,040 | 0.02% |
| Verition Fund Management LLC | 1,784 | $1,107,150 | 0.01% |
| Citadel Advisors | 84,195,000 | $57,252,600 | 0.01% |
| GAMCO INVESTORS, INC. ET AL | 300,000 | $186,450 | 0.00% |
| MORGAN STANLEY | 130,000 | $80,002 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 2,453,000 | $1,498,892 | 0.00% |
This page lists CARDLYTICS INC's shareholders in Q3 2023. To view CARDLYTICS INC's shareholder history, click here.